China Uterine Cancer Market Size & Outlook, 2025-2033


China Uterine Cancer Market Insights

  • Reed Intelligence analysis indicates that the China Uterine Cancer Market size, valued at USD 413 Million in 2024, is expected to expand to USD 628.92 Million by 2033.
  • The China market is forecasted to expand at a CAGR of 4.76% spanning 2026–2033.
  • Endometrial Adenocarcinoma held the leading position among By Type segments in 2024, based on market size.
  • Adenosquamous Carcinoma is projected to post the fastest growth rate, sustaining its position as the most attractive By Type segment during the forecast horizon.

Other Key Findings


  • As of 2024, China held 6.6% of the global Uterine Cancer Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Uterine Cancer Market.
  • In Asia Pacific, China is expected to lead the regional Uterine Cancer Market size by 2033.
  • South Korea will remain the fastest-growing market in Asia Pacific, reaching USD 82.51 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 413 Million
Market Size In 2033 USD 628.92 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 4.76% (2025-2033)
Segmnetation Covered
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends